Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni

This study has been completed.
Sponsor:
Collaborator:
Dafra Pharma
Information provided by:
Kenya Medical Research Institute
ClinicalTrials.gov Identifier:
NCT01054651
First received: January 21, 2010
Last updated: NA
Last verified: January 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
No publications provided by Kenya Medical Research Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):